Bo Ying

Bo Ying

Company: AboGen Inc.

Job title: Chief Executive Officer

Seminars:

Unlocking Recent Clinical Progress of mRNA-Based Vaccines & B-Cell Depletion Therapies 9:00 am

Demonstrating Abogen’s unique mRNA and LNP platform Sharing clinical data and progress of mRNA cancer vaccines Accelerating preclinical and clinical development of mRNA-based T-cell engagers and in vivo CAR-TRead more

day: Conference Day One

CEO Leaders Think Tank – Accelerating the Next Wave of RNA-Based Therapeutics & Vaccines to Develop Safe & Efficacious Drugs to Commercial Reality 10:00 am

The Asian biopharmaceutical sector is thriving in RNA innovation, manufacturing advancements and strategic alliances to enhance the knowledge, skills, and experience across the region to become the powerhouse of commercial success. Hear from pioneering executive leaders across mRNA and next generation RNAs who will discuss their ambitions, strategies and challenges for the future of this…Read more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.